Variant report
Variant | nsv470944 |
---|---|
Chromosome Location | chr10:56642818-56682226 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:56637516..56639044-chr10:56640862..56643411,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553013904 | chr10:56654303-56654304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs185732166 | chr10:56654321-56654322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11004625 | chr10:56654322-56654323 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs66511024 | chr10:56654335-56654336 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs72798539 | chr10:56654403-56654404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146237758 | chr10:56654511-56654512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183078777 | chr10:56654558-56654559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539036167 | chr10:56654573-56654574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543656185 | chr10:56654579-56654580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563630251 | chr10:56654708-56654709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73259942 | chr10:56654712-56654713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs80110230 | chr10:56654752-56654753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557222065 | chr10:56662003-56662004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147845288 | chr10:56662016-56662017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187969287 | chr10:56662043-56662044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546203702 | chr10:56662105-56662106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191274811 | chr10:56662132-56662133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs532598030 | chr10:56662143-56662144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs79597548 | chr10:56662224-56662225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545503436 | chr10:56662277-56662278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs558608400 | chr10:56662282-56662283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs74457297 | chr10:56662293-56662294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565407947 | chr10:56662299-56662300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs79372152 | chr10:56662312-56662313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs80238485 | chr10:56662319-56662320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76177506 | chr10:56662323-56662324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141178598 | chr10:56662450-56662451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs202193110 | chr10:56662495-56662496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556785041 | chr10:56662537-56662538 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150295275 | chr10:56662538-56662539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546242216 | chr10:56662568-56662569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566445055 | chr10:56662596-56662597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1454471 | chr10:56662603-56662604 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs551849772 | chr10:56662606-56662607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568651175 | chr10:56662629-56662630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75414626 | chr10:56662690-56662691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374665780 | chr10:56662772-56662773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544396873 | chr10:56662797-56662798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149484289 | chr10:56662904-56662905 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567833074 | chr10:56662913-56662914 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs117833151 | chr10:56662922-56662923 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114536281 | chr10:56662924-56662925 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201708690 | chr10:56662948-56662949 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574995012 | chr10:56662960-56662961 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573170521 | chr10:56663022-56663023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201682336 | chr10:56663030-56663031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs201919389 | chr10:56663031-56663032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184109274 | chr10:56663054-56663055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1542351 | chr10:56663191-56663192 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs575820012 | chr10:56663202-56663203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
small cell lung cancer | 17426248 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56654200-56654800 | Enhancers | Fetal Heart | heart |
2 | chr10:56662000-56663000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr10:56662200-56662600 | Enhancers | H9 Cell Line | embryonic stem cell |
4 | chr10:56662200-56663000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr10:56662200-56663000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr10:56662400-56662800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr10:56662400-56663000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr10:56662800-56666600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
9 | chr10:56663000-56666600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr10:56663000-56674000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
11 | chr10:56663600-56663800 | Enhancers | Brain Germinal Matrix | brain |
12 | chr10:56664400-56667000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr10:56665200-56666000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr10:56665400-56665800 | Enhancers | Brain Germinal Matrix | brain |
15 | chr10:56666600-56667000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr10:56666600-56667000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr10:56666600-56667000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr10:56669000-56669400 | Enhancers | Fetal Muscle Trunk | muscle |
19 | chr10:56673800-56674200 | Enhancers | HUVEC | blood vessel |